Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Plasma metabolomics profiling for the prediction of cytomegalovirus DNAemia and analysis of virus–host interaction in allogeneic stem cell transplant recipients.

Monleón D, Giménez E, Muñoz-Cobo B, Morales JM, Solano C, Amat P, Navarro D.

J Gen Virol. 2015 Nov;96(11):3373-81.

PMID:
26341195
2.

Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease.

San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martin-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM; REIPI Network, Spain; GESITRA Study Group from the SEIMC.

J Infect. 2015 Nov;71(5):561-70. doi: 10.1016/j.jinf.2015.06.013. Epub 2015 Jul 14.

PMID:
26183297
3.

Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.

San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM; REIPI Network.

Transpl Infect Dis. 2015 Oct;17(5):637-46. doi: 10.1111/tid.12417. Epub 2015 Aug 27.

PMID:
26134282
4.

Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting.

Giménez E, Blanco-Lobo P, Muñoz-Cobo B, Solano C, Amat P, Pérez-Romero P, Navarro D.

J Gen Virol. 2015 Sep;96(9):2822-31. doi: 10.1099/vir.0.000203. Epub 2015 May 29.

PMID:
26025872
5.

Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.

Giménez E, Muñoz-Cobo B, Solano C, Amat P, de la Cámara R, Nieto J, López J, Remigia MJ, Garcia-Noblejas A, Navarro D.

Transpl Infect Dis. 2015 Jun;17(3):361-70. doi: 10.1111/tid.12391. Epub 2015 Jun 1.

PMID:
25850900
6.

Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?

Giménez E, Muñoz-Cobo B, Solano C, Amat P, Navarro D.

J Clin Microbiol. 2014 Feb;52(2):654-6. doi: 10.1128/JCM.02571-13. Epub 2013 Nov 27.

7.

An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.

Muñoz-Cobo B, Giménez E, Solano C, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Navarro D.

J Med Virol. 2014 May;86(5):806-11. doi: 10.1002/jmv.23742. Epub 2013 Sep 16.

PMID:
24105728
8.

An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.

Giménez E, Solano C, Nieto J, Remigia MJ, Clari MÁ, Costa E, Muñoz-Cobo B, Amat P, Bravo D, Benet I, Navarro D.

J Med Virol. 2014 Apr;86(4):568-75. doi: 10.1002/jmv.23735. Epub 2013 Sep 13.

PMID:
24037906
9.

Frequent detection of cytomegalovirus (CMV) DNA in the lower respiratory tract in CMV-seropositive pediatric patients with underlying chronic bronchopulmonary diseases lacking canonical immunosuppression.

Escribano A, Chilet M, Clari MÁ, Lucas R, Costa E, Bravo D, Muñoz-Cobo B, Borrás R, Navarro D.

J Med Virol. 2013 May;85(5):888-92. doi: 10.1002/jmv.23499. Epub 2013 Feb 13.

PMID:
23408504
10.

Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center.

Solano C, Muñoz-Cobo B, Giménez E, Remigia MJ, Amat P, Clari MA, Bravo D, Benet I, Montoro J, Navarro D.

Bone Marrow Transplant. 2013 Jul;48(7):1010-2. doi: 10.1038/bmt.2012.286. Epub 2013 Jan 21. No abstract available.

PMID:
23334275
11.

Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.

Clari MÁ, Bravo D, Costa E, Muñoz-Cobo B, Solano C, Remigia MJ, Giménez E, Benmarzouk-Hidalgo OJ, Pérez-Romero P, Navarro D.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):207-9. doi: 10.1016/j.diagmicrobio.2012.10.010. Epub 2012 Nov 20.

PMID:
23182073
12.

Low rate of detection of active cytomegalovirus (CMV) infection early following acute myocardial infarction.

Núñez J, Chilet M, Blasco ML, Clari MA, Sanjuan R, Muñoz-Cobo B, Bodí V, Costa E, Bravo D, Sanchis J, Miñana G, Navarro D.

Atherosclerosis. 2012 May;222(1):295-7. doi: 10.1016/j.atherosclerosis.2012.02.022. Epub 2012 Feb 21. No abstract available.

PMID:
22420892
13.

Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.

Clari MÁ, Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, Bravo D, Amat P, Navarro D.

Clin Vaccine Immunol. 2012 May;19(5):791-6. doi: 10.1128/CVI.05633-11. Epub 2012 Feb 29.

14.

Performance of an immunofiltration assay detecting IgM antibodies against ZEBRA and viral capsid p18 proteins (Immunoquick(®) filtration EBV M) for the diagnosis of heterophile antibody-negative primary Epstein-Barr virus infection in children.

Meza LD, Sancho-Tello S, Muñoz-Cobo B, Costa E, Bravo D, Pazos JM, Corrales I, Marcano X, Tohalino M, Navarro D.

J Clin Virol. 2012 Mar;53(3):270-1. doi: 10.1016/j.jcv.2011.12.008. Epub 2011 Dec 30. No abstract available.

PMID:
22209289
15.

Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.

Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Bravo D, Clari MÁ, Navarro D.

J Med Virol. 2012 Feb;84(2):259-67. doi: 10.1002/jmv.22254.

PMID:
22170546
16.

Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients.

Blanquer J, Chilet M, Benet I, Aguilar G, Muñoz-Cobo B, Tellez A, Costa E, Bravo D, Navarro D.

J Med Virol. 2011 Nov;83(11):1966-71. doi: 10.1002/jmv.22202.

PMID:
21915872
17.

Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies.

Muñoz-Cobo B, Solano C, Costa E, Bravo D, Clari MÁ, Benet I, Remigia MJ, Montoro J, Navarro D.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1602-11. doi: 10.1016/j.bbmt.2011.08.014. Epub 2011 Aug 24.

18.

Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.

Solano C, Benet I, Remigia MJ, de la Cámara R, Muñoz-Cobo B, Costa E, Clari MÁ, Bravo D, Amat P, Navarro D.

Transplantation. 2011 Aug 27;92(4):e17-20. doi: 10.1097/TP.0b013e318224f263. No abstract available.

PMID:
21814124
19.

Effect of cytomegalovirus (CMV) serostatus on the incidence and virological features of active CMV infection in allogeneic stem cell transplant recipients.

Solano C, Tormo N, de la Cámara R, Bartolo Nieto J, López J, Benet I, Muñoz-Cobo B, Costa E, Remigia MJ, Garcia-Noblejas A, Bravo D, Navarro D.

Clin Infect Dis. 2011 Aug 1;53(3):313-5; author reply 315-6. doi: 10.1093/cid/cir414. No abstract available.

PMID:
21765090
20.

Performance of the LightCycler SeptiFast test Mgrade in detecting microbial pathogens in purulent fluids.

Sancho-Tello S, Bravo D, Borrás R, Costa E, Muñoz-Cobo B, Navarro D.

J Clin Microbiol. 2011 Aug;49(8):2988-91. doi: 10.1128/JCM.00359-11. Epub 2011 Jun 29.

21.

Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.

Bravo D, Clari MÁ, Costa E, Muñoz-Cobo B, Solano C, José Remigia M, Navarro D.

J Clin Microbiol. 2011 Aug;49(8):2899-904. doi: 10.1128/JCM.00785-11. Epub 2011 Jun 22.

22.

Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients.

Bravo D, Blanquer J, Tormo M, Aguilar G, Borrás R, Solano C, Clari MA, Costa E, Muñoz-Cobo B, Argüeso M, Pineda JR, Navarro D.

Int J Infect Dis. 2011 May;15(5):e326-31. doi: 10.1016/j.ijid.2011.01.003. Epub 2011 Feb 24.

23.

Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest.

Muñoz-Cobo B, Sancho-Tello S, Costa E, Bravo D, Torregrosa I, de Lomas JG, Navarro D.

Int J Antimicrob Agents. 2011 Mar;37(3):278-9. doi: 10.1016/j.ijantimicag.2010.12.004. Epub 2011 Jan 26. No abstract available.

PMID:
21269809
24.

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.

Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D.

Bone Marrow Transplant. 2011 Nov;46(11):1437-43. doi: 10.1038/bmt.2010.330. Epub 2011 Jan 17.

PMID:
21243030
25.

Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection.

Muñoz-Cobo B, Solano C, Nieto J, de la Cámara R, Remigia MJ, Garcia-Noblejas A, López J, Benet I, Hernández-Boluda JC, Costa E, Bravo D, Navarro D.

Bone Marrow Transplant. 2011 Nov;46(11):1484-6. doi: 10.1038/bmt.2010.322. Epub 2011 Jan 10. No abstract available.

PMID:
21217790
26.

Sensitivity of a marketed immunochromatographic assay specifically targeting the pandemic influenza A/H1N1 2009 virus.

Gimeno C, Costa E, Navalpotro D, Bravo D, Ocete D, Clari MA, Tormo N, Muñoz-Cobo B, de Lomas JG, Navarro D.

Diagn Microbiol Infect Dis. 2010 Sep;68(1):80-2. doi: 10.1016/j.diagmicrobio.2010.05.005.

PMID:
20727475
27.

Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulin m assays on the liaison platform with sera from patients displaying acute parvovirus B19 infection.

Costa E, Tormo N, Clari MA, Bravo D, Muñoz-Cobo B, Navarro D.

Clin Vaccine Immunol. 2009 Aug;16(8):1247-8. doi: 10.1128/CVI.00142-09. Epub 2009 Jul 1.

28.

Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patients.

Bravo D, Muñoz-Cobo B, Costa E, Clari MA, Tormo N, Navarro D.

Clin Vaccine Immunol. 2009 Jun;16(6):885-8. doi: 10.1128/CVI.00123-09. Epub 2009 Apr 29.

Supplemental Content

Loading ...
Support Center